CENCORA, INC. for CENCORA, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortage Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicares Part B Physician Fee Schedule CMS ASP Certification Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule Distributor bona fide service fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Pharmacy PHA
Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Health Issues HCR
Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act (NDAA - H.R.8800) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS FY 2026 Medicares Part B Physician Fee Schedule Rule CMS ASP Certification Break Up Big Medicine Act (S. 3822) Management Services Organization (MSO) Role and value of community specialty physicians and MSOs Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Taxation/Internal Revenue Code TAX
Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Trade (domestic/foreign) TRD
Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| FREDERICK ESSIS | — |
| COREY AUSTIN MCGEE | — |
| VIVIENNE STAFFORD MITCHELL | — |
| SHELLY MUI-LIPNIK | — |
| DARRELL ROGERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.